Literature DB >> 34264267

Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.

Damon E Houghton1, Henny Heisler Billett2, Manila Gaddh3, Oluwatomiloba Onadeko4, Gemlyn George5, Tzu-Fei Wang6, Thein H Oo7, Mingen Feng8, Mahua Dasgupta8, Michael Jaglal9, Michael B Streiff10, Pippa Simpson8, Radhika Gali11, Lisa Baumann Kreuziger8,12.   

Abstract

Standard treatment of catheter-associated upper extremity deep vein thrombosis (UE-DVT) is anticoagulation, although catheters are often removed for this indication. The optimal time for catheter removal and whether the act and/or timing of catheter removal is associated with pulmonary embolism (PE) remain unknown. A retrospective cohort study was performed at 8 participating institutions through the Venous thromboEmbolism Network US. Patients with hematologic malignancies and central venous catheter (CVC)-associated UE-DVT were included from 1 January 2010 through 31 December 2016. The primary outcome was objectively confirmed PE within 7 days of UE-DVT diagnosis in anticoagulated patients comparing early (≤48 hours) vs delayed (>48 hours) catheter removal. A total of 626 patients were included, among whom 480 were treated with anticoagulation. Among anticoagulated patients, 255 underwent early CVC removal, while 225 had delayed or no CVC removal; 146 patients received no anticoagulation, among whom 116 underwent CVC removal alone. PE within 7 days occurred in 2 patients (0.78%) with early removal compared with 1 patient (0.44%) with delayed or no CVC removal (P > .9). PE or any cause of death within 7 days occurred in 3 patients in both the early removal (1.18%) and delayed/no removal (1.33%) groups (P > .9). In patients treated with CVC removal only (no anticoagulation), there were no PEs but 3 deaths within 7 days. In patients with hematological malignancy and CVC-associated UE-DVT, early removal of CVCs was not associated with an increased risk of PE compared with delayed or no removal.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34264267      PMCID: PMC8341352          DOI: 10.1182/bloodadvances.2021004698

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  19 in total

1.  Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.

Authors:  Hylton V Joffe; Nils Kucher; Victor F Tapson; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

2.  Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH.

Authors:  J I Zwicker; G Connolly; M Carrier; P W Kamphuisen; A Y Y Lee
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

Review 3.  International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.

Authors:  P Debourdeau; D Farge; M Beckers; C Baglin; R M Bauersachs; B Brenner; D Brilhante; A Falanga; G T Gerotzafias; N Haim; A K Kakkar; A A Khorana; R Lecumberri; M Mandala; M Marty; M Monreal; S A Mousa; S Noble; I Pabinger; P Prandoni; M H Prins; M H Qari; M B Streiff; K Syrigos; H R Büller; H Bounameaux
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

4.  The efficacy and safety of a catheter removal only strategy for the treatment of PICC line thrombosis versus standard of care anticoagulation: a retrospective review.

Authors:  Joseph J Shatzel; Dylan Mart; Jeffrey Y Bien; Ashray Maniar; Sven Olson; Timothy K Liem; Thomas G DeLoughery
Journal:  J Thromb Thrombolysis       Date:  2019-05       Impact factor: 2.300

5.  The treatment and outcome of cancer patients with thromboses on central venous catheters.

Authors:  D A Frank; J Meuse; D Hirsch; J G Ibrahim; A D van den Abbeele
Journal:  J Thromb Thrombolysis       Date:  2000-12       Impact factor: 2.300

6.  Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.

Authors:  Lisa Baumann Kreuziger; Manila Gaddh; Oluwatomiloba Onadeko; Gemlyn George; Tzu-Fei Wang; Thein H Oo; Michael Jaglal; Damon E Houghton; Michael B Streiff; Radhika Gali; Mingen Feng; Pippa Simpson; Henny H Billett
Journal:  Thromb Res       Date:  2021-04-06       Impact factor: 3.944

7.  Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry.

Authors:  Lauren P Cote; Steven Greenberg; Joseph A Caprini; Alfonso Tafur; Chris Choi; Francisco J Muñoz; Andris Skride; Beatriz Valero; José Antonio Porras; Maurizio Ciammaichella; Luis Manuel Hernández-Blasco; Manuel Monreal
Journal:  Clin Appl Thromb Hemost       Date:  2016-08-29       Impact factor: 2.389

8.  Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.

Authors:  Bethany T Samuelson; Terry Gernsheimer; Elihu Estey; David A Garcia
Journal:  Thromb Res       Date:  2016-03-12       Impact factor: 3.944

Review 9.  Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.

Authors:  Vineet Chopra; Sarah Anand; Andy Hickner; Michael Buist; Mary Am Rogers; Sanjay Saint; Scott A Flanders
Journal:  Lancet       Date:  2013-05-20       Impact factor: 79.321

10.  Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.

Authors:  Damon E Houghton; Nigel S Key; Neil A Zakai; Jeffrey P Laux; Thomas C Shea; Stephan Moll
Journal:  Leuk Lymphoma       Date:  2017-04-09
View more
  4 in total

1.  Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care.

Authors:  Juan Carlos Laguna; Tim Cooksley; Shin Ahn; Nikolaos Tsoukalas; Thein Hlaing Oo; Norman Brito-Dellan; Francis Esposito; Carmen Escalante; Carme Font
Journal:  Support Care Cancer       Date:  2022-08-06       Impact factor: 3.359

2.  [Chinese expert consensus on the diagnosis and treatment of venous thromboembolism after hematopoietic stem cell transplantation (2022)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-03-14

3.  Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis.

Authors:  Demis N Lipe; Aiham Qdaisat; Eva Rajha; Aisha Al-Breiki; Maria T Cruz Carreras; Patrick Chaftari; Sai-Ching J Yeung; Terry W Rice
Journal:  Res Pract Thromb Haemost       Date:  2022-08-19

4.  EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer.

Authors:  Anna Falanga; Avi Leader; Chiara Ambaglio; Zsuzsa Bagoly; Giancarlo Castaman; Ismail Elalamy; Ramon Lecumberri; Alexander Niessner; Ingrid Pabinger; Sebastian Szmit; Alice Trinchero; Hugo Ten Cate; Bianca Rocca
Journal:  Hemasphere       Date:  2022-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.